GlycoMimetics Competitors and Similar CompaniesClear all
GlycoMimetics's competitors and similar companies include DAVA Oncology, Actuate Therapeutics, Galecto and Takeda.
 GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  DAVA Oncology DAVA Oncology is a company that provides solutions and services to the pharmaceutical and biotechnology industries aiming to support cancer drug development. |  Actuate Therapeutics Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic agents for patients with cancer or inflammatory diseases. |  Galecto Galecto Biotech is a company that develops small molecules for the treatment of severe diseases, including fibrosis, cancer, and inflammation. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | |
Founding Date | Founding Date 2003 | Founding Date 2007 | Founding Date 2015 | Founding Date 2011 | Founding Date 1781 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Rockville, US HQ | Locations Dallas, US HQ | Locations Fort Worth, US HQ Dublin, IE | Locations København, DK HQ | |
Employees | Employees 5025% increase | Employees 823% increase | Employees 1067% increase | Employees 5 | Employees 47,4554% decrease |
Valuation ($) | Valuation ($) 31.6 m | Valuation ($) N/A | Valuation ($) 180.3 m | Valuation ($) 9.3 m | Valuation ($) 43.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) |
Net income | Net income ($153.9m) (FY, 2025) | Net income N/A | Net income ($22.2m) (FY, 2025) | Net income ($209.8m) (FY, 2025) | Net income ¥108.1b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 101.8m | Total funding raised N/A | Total funding raised $ 31.2m | Total funding raised $ 64m | Total funding raised $ 57.8m |
For sources of this data, please see the company profile
View Company Profiles
DAVA Oncology
HQ
Dallas, US
Employees
82↑ 3% increase
DAVA Oncology is a company that provides solutions and services to the pharmaceutical and biotechnology industries aiming to support cancer drug development.
View companyActuate Therapeutics
HQ
Fort Worth, US
Employees
10
Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic agents for patients with cancer or inflammatory diseases.
View companyGalecto
HQ
København, DK
Employees
5
Galecto Biotech is a company that develops small molecules for the treatment of severe diseases, including fibrosis, cancer, and inflammation.
View companyTakeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View company